| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
| 9,025 | | | Gross Profit |
-
|
-
| (9,025) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,353 | 4,343 | 8,786 | | Non Recurring |
-
|
-
|
-
| | Others | 31 | 56 | 7 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,384) | (4,399) | (17,818) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,595) | 275 | (230) | | Earnings Before Interest And Taxes | (4,979) | (4,124) | (17,893) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (4,979) | (4,124) | (17,893) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,979) | (4,124) | (18,048) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,979) | (4,124) | (18,048) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,979) | ($4,124) | ($18,048) |
|
0.51% Nasdaq 
Income Statement
